Friday, July 10, 2026

biotech · NSCLC Stage IV · Poliomyelitis

BioMarin Pharmaceutical

BioMarin Pharmaceutical clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

770 Lindaro Street, San Rafael, CA 94901, US HQ
1997 Founded
3,171 Employees
NMPA registrant Type
Company details
Status
Public
HQ
770 Lindaro Street, San Rafael, CA 94901, US
Founded
1997
Employees
3,171
Programs
40
Drugs
37
Patents
0
Intelligence · Clinical Programs

BioMarin Pharmaceutical projects

3 ClinicalTrials.gov programs sponsored by BioMarin Pharmaceutical.

BioMarin Pharmaceutical has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 2wIPV+1sIPV

    Biotech Pharmaceutical Co.,

    Poliomyelitis

    approved mab active

    1 trial
  2. Taneasy 600mg granules

    Biotech Pharmaceutical Co.,

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule completed

    1 trial
  3. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does BioMarin Pharmaceutical have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.